South Korea’s Edenlux set for U.S. debut of eye-strain wellness device

South Korea-based Edenlux, founded by medical doctor Sungyong Park, is preparing to launch its second eye-strain wellness device, Eyeary, in the U.S. market via an Indiegogo campaign planned for late March. The company’s mission stems from Park’s personal experience with temporary eye muscle paralysis, which inspired him to develop technology aimed at protecting and restoring vision amid increasing screen time. Eyeary is a daily visual recovery tool designed to be faster and more user-friendly than Edenlux’s first product, Otus, a bulky VR-style device launched in 2022 across several Asian markets that has generated $10 million in revenue. Eyeary resembles normal glasses, is lighter, and features a lens system with 144 diopter focal points for precise eye-muscle training, compared to Otus’s five focal points. Eyeary pairs with a mobile app via Bluetooth to collect usage data, which Edenlux analyzes using AI to customize training programs and predict improvement timelines. The device targets the c